Cachexia, literally “bad condition”, a syndrome reported even in the Old Testament, is associated to a variety of chronic diseases and to several kinds of traumatic injuries. Although an official definition of cachexia is still missing, this multi systemic syndrome is characterized by a massive loss of skeletal muscle and fat tissue. Such an important loss of body mass is often a direct cause of death, interferes with therapies and always represents a poor prognostic factor. In sharp contrast with the management of chronic disease states, a cure for cachexia is still missing. In recent years striking discoveries have cast light upon the molecular mechanisms underlying cachexia. Muscle specific targets for pharma-cological, gene or cell therapy approaches have been identified and are summarized in this review. Although limited to cancer cachexia, the first phase I-III clinical trials have been recently terminated or are ongoing. These efforts are opening the possibility to prevent cachexia or treat it with novel approaches in the near future.
CACHEXIA: NOVEL PERSPECTIVES FOR AN OLD SYNDROME / Coletti, Dario; Belli, L; Adamo, Sergio. - In: BASIC AND APPLIED MYOLOGY. - ISSN 1120-9992. - STAMPA. - 16:5&6(2006), pp. 131-139.
CACHEXIA: NOVEL PERSPECTIVES FOR AN OLD SYNDROME
COLETTI, Dario;ADAMO, Sergio
2006
Abstract
Cachexia, literally “bad condition”, a syndrome reported even in the Old Testament, is associated to a variety of chronic diseases and to several kinds of traumatic injuries. Although an official definition of cachexia is still missing, this multi systemic syndrome is characterized by a massive loss of skeletal muscle and fat tissue. Such an important loss of body mass is often a direct cause of death, interferes with therapies and always represents a poor prognostic factor. In sharp contrast with the management of chronic disease states, a cure for cachexia is still missing. In recent years striking discoveries have cast light upon the molecular mechanisms underlying cachexia. Muscle specific targets for pharma-cological, gene or cell therapy approaches have been identified and are summarized in this review. Although limited to cancer cachexia, the first phase I-III clinical trials have been recently terminated or are ongoing. These efforts are opening the possibility to prevent cachexia or treat it with novel approaches in the near future.File | Dimensione | Formato | |
---|---|---|---|
CACHEXIA-BAM final 2006.pdf
solo gestori archivio
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
281.7 kB
Formato
Adobe PDF
|
281.7 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.